Detalhe da pesquisa
1.
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer.
Nature
; 612(7940): 495-502, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450981
2.
Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC).
Br J Cancer
; 129(5): 782-790, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37443348
3.
GOBLET: a phase I/II study of pelareorep and atezolizumab +/- chemo in advanced or metastatic gastrointestinal cancers.
Future Oncol
; 18(26): 2871-2878, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35796248
4.
Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial.
Clin Infect Dis
; 70(2): 181-190, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30843046
5.
ENGINE: a Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1.
Future Oncol
; 16(15): 991-999, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32250167
6.
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial.
Cancer
; 125(8): 1301-1312, 2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30707761
7.
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
N Engl J Med
; 375(11): 1019-32, 2016 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27626517
8.
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.
JAMA
; 322(2): 123-133, 2019 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31287523
9.
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older.
J Infect Dis
; 217(11): 1750-1760, 2018 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29529222
10.
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
N Engl J Med
; 372(22): 2087-96, 2015 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25916341
11.
Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
J Infect Dis
; 216(11): 1343-1351, 2017 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029122
12.
Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older.
J Infect Dis
; 216(11): 1352-1361, 2017 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029224
13.
Erratum to: Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age.
J Infect Dis
; 223(2): 353, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215671
14.
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.
Blood
; 124(19): 2921-9, 2014 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25237196
15.
Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study.
J Infect Dis
; 211(8): 1279-87, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25371534
16.
Efficacy results of a trial of a herpes simplex vaccine.
N Engl J Med
; 366(1): 34-43, 2012 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22216840
17.
Idiopathic Chronic Parotitis: Imaging Findings and Sialendoscopic Response.
ORL J Otorhinolaryngol Relat Spec
; 77(5): 302-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26376430
18.
Correlate of immune protection against HSV-1 genital disease in vaccinated women.
J Infect Dis
; 209(6): 828-36, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24285844
19.
HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).
South Med J
; 107(2): 79-84, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24926671
20.
Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age.
J Infect Dis
; 208(12): 1953-61, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23904292